Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Time to clinical benefit was assessed. The x-axis represents time from randomization, and the y-axis represents the degree of benefit at that time, as measured by the hazard ratio shown in blue. The ...

A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney disease, diabetic retinopathy, and diabetic neuropathy. The study maps shared ...

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the ...

eGFRdiff and GDF-15 are independent predictors of chronic kidney disease progression and mortality in diabetes, highlighting their potential for risk stratification in clinical practice. Kidney ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...

Managing mental and emotional health is a key part of managing chronic kidney disease.